Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Sam Isaly, Orbimed Now Hold 53.3% of Response Biomedical

Sam Isaly‘s Orbimed Advisors focuses on healthcare investments, and it has now disclosed a change to its holdings of Response Biomedical Corp. (ADR)(OTCBB:RPBIF), a rapid on-site diagnostic test provider. The fund now holds 53.3% of the micro-cap’s outstanding shares, down from the 54.6% stake it last reported in 2012.

CMYK_logo_secondary_response_biomedical_2-250x84

Disclosure: none

Recommended Reading:

Paul Singer Reiterates 6.4% Stake in Emulex, Reveals New Agreement in Play

Eric Bannasch’s Cadian Capital Lowers Stake in LogMeIn

Glenn Greenberg’s Brave Warrior Capital Cuts Stake in Higher One Holdings

Loading...